Patent details

Basic Information

Publication number:

EP1202961

PCT Application Number:

PCT/EP/2000/007641

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP009514811

PCT Publication Number:

WO/2001/010827

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

ARYLSULFONAMIDO-SUBSTITUTED HYDROXAMIC ACID DERIVATIVES

French Title of Invention:

DERIVES D'ACIDE HYDROXAMIQUE ARYLSULFONAMIDO-SUBSTITUES

German Title of Invention:

ARYLSULFONAMID-SUBSTITUIERTE HYDROXAMSÄURE-DERIVATE

SPC Number:

Dates

Filing date:

07/08/2000

Grant date:

20/01/2010

EP Publication Date:

20/01/2010

PCT Publication Date:

15/02/2001

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/05/2002

EP B1 Publication Date:

20/01/2010

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

07/08/2010

Expiration date:

07/08/2020

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

07/08/2000

 

 

Name:

Novartis AG

Address:

Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:

KASAOKA Tatsuhiko

Address:

Japan (JP)

2

Name:

KOIZUMI Shinichi

Address:

Japan (JP)

3

Name:

SAKAKI Junichi

Address:

Japan (JP)

4

Name:

NAKAJIMA Motowo

Address:

Japan (JP)

5

Name:

MATSUNAGA Shinichiro

Address:

Japan (JP)

6

Name:

IWASAKI Genji

Address:

Japan (JP)

7

Name:

KANAZAWA Takanori

Address:

Japan (JP)

8

Name:

BREITENSTEIN Werner

Address:

Switzerland (CH)

9

Name:

HAYAKAWA Kenji

Address:

Japan (JP)

Priority

Priority Number:

9918684

Priority Date:

09/08/1999

Priority Country:

United Kingdom (GB)

Classification

Main IPC Class:

C07C 311/29;

Filing date	Document type	Number of pages